These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? Sterns RH; Rojas M; Bernstein P; Chennupati S J Am Soc Nephrol; 2010 May; 21(5):733-5. PubMed ID: 20167700 [TBL] [Abstract][Full Text] [Related]
24. Ileocolic perforation secondary to sodium polystyrene sulfonate in sorbitol use: a case report. Trottier V; Drolet S; Morcos MW Can J Gastroenterol; 2009 Oct; 23(10):689-90. PubMed ID: 19826644 [TBL] [Abstract][Full Text] [Related]
25. Colonic necrosis due to sodium polystyrene sulfate (Kayexalate). Bomback AS; Woosley JT; Kshirsagar AV Am J Emerg Med; 2009 Jul; 27(6):753.e1-2. PubMed ID: 19751641 [TBL] [Abstract][Full Text] [Related]
28. Acute abdomen with colonic necrosis induced by Kayexalate-sorbitol. Dardik A; Moesinger RC; Efron G; Barbul A; Harrison MG South Med J; 2000 May; 93(5):511-3. PubMed ID: 10832954 [TBL] [Abstract][Full Text] [Related]
29. Inflammatory Pseudotumor Containing Kayexalate Crystals: A Case Report and Review of the Literature. Romano RC; Thirumala S; Cushman WH; Mounajjed T Int J Surg Pathol; 2014 Aug; 22(5):464-9. PubMed ID: 24178951 [TBL] [Abstract][Full Text] [Related]
30. The Successful Treatment of Sodium Polystyrene Sulfonate-induced Enteritis Diagnosed by Small Bowel Endoscopy. Okayama K; Hirata Y; Kumai D; Yamamoto Y; Kojima Y; Kanno T; Ikeuchi H; Mochizuki H; Takada H; Sobue S Intern Med; 2018 Jun; 57(11):1577-1581. PubMed ID: 29321412 [TBL] [Abstract][Full Text] [Related]
31. Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age. Noel JA; Bota SE; Petrcich W; Garg AX; Carrero JJ; Harel Z; Tangri N; Clark EG; Komenda P; Sood MM JAMA Intern Med; 2019 Aug; 179(8):1025-1033. PubMed ID: 31180477 [TBL] [Abstract][Full Text] [Related]
32. Resin treatment of hyperkalemia. II. Clinical experience with a cation exchange resin (calcium cycle). Frohnert PP; Johnson WJ; Mueller GJ; Tauxe WN; McCall JT J Lab Clin Med; 1968 May; 71(5):840-6. PubMed ID: 5647685 [No Abstract] [Full Text] [Related]
33. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease. Georgianos PI; Liampas I; Kyriakou A; Vaios V; Raptis V; Savvidis N; Sioulis A; Liakopoulos V; Balaskas EV; Zebekakis PE Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620 [TBL] [Abstract][Full Text] [Related]
34. Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings. Abraham SC; Bhagavan BS; Lee LA; Rashid A; Wu TT Am J Surg Pathol; 2001 May; 25(5):637-44. PubMed ID: 11342776 [TBL] [Abstract][Full Text] [Related]
35. [Sodium polystyrene sulfonate (Resonium A) as possible cause of rectal blood loss]. Schiere S; Karrenbeld A; Tulleken JE; van der Werf TS; Zijlstra JG Ned Tijdschr Geneeskd; 1997 Nov; 141(44):2127-9. PubMed ID: 9550776 [TBL] [Abstract][Full Text] [Related]
36. Damned if you do, damned if you don't: potassium binding resins in hyperkalemia. Watson M; Abbott KC; Yuan CM Clin J Am Soc Nephrol; 2010 Oct; 5(10):1723-6. PubMed ID: 20798253 [TBL] [Abstract][Full Text] [Related]